Oncoscience | Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients
IJTM | Free Full-Text | Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
![Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-021-00869-5/MediaObjects/13550_2021_869_Fig1_HTML.png "Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text")
Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text
Day 3,508 – PSA Results - Cancer Health
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
El tiempo de doblaje de PSA como nuevo método diagnóstico y pronóstico del cáncer de próstata
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resista
A Commentary on PSA Velocity and Doubling Time for Clinical Decisions in Prostate Cancer
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
PSA velocity and doubling time in diagnosis and prognosis of prostate cancer
Summary of PSA Doubling Time and Velocity Definitions | Download Table
PROSTATE SPECIFIC ANTIGEN DOUBLING TIME AFTER RADICAL PROSTATECTOMY: EFFECT OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY | Journal of Urology
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
PSA doubling time (PSADT) and proximal PSA predict metastasis-free survival (MFS) in men with biochemically recurrent prostate c
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time | American Society of Clinical Oncology Educational Book
Calculadoras – Urología Basada en Evidencia
Oncology Resources - EOS | Emirates Oncology Society
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Proposal for a Standardized PSA Doubling-time Calculation
The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
